Predictive Value of GAD Antibody for Diabetes in Normal Chinese Adults: A Retrospective Cohort Study in China
- PMID: 33688223
- PMCID: PMC7935353
- DOI: 10.2147/DMSO.S298068
Predictive Value of GAD Antibody for Diabetes in Normal Chinese Adults: A Retrospective Cohort Study in China
Abstract
Purpose: To investigate the prevalence of GAD antibody (GADA) in the general adult population and to evaluate its predictive value for diabetes in China.
Patients and methods: We searched the PUMCH-HM database and identified 36,731 adult subjects with GADA test results from 2012 to 2015. We then established a retrospective cohort of 4835 nondiabetic subjects at baseline with complete annual health evaluation records through 2019. The median follow-up time was 4.8 (3.0-7.3) years.
Results: The overall prevalence of GADA was 0.53% and was higher in diabetic subjects (1.25%) than in nondiabetic subjects (0.47%). We found a decrease in baseline body mass index (BMI) from the GADA- to GADAhigh subgroups among baseline diabetic and prediabetic patients and also those who developed diabetes later in the cohort study. A total of 136 subjects (2.8%) developed diabetes after a median follow-up of 3.5 years. For GADA+ participants, BMI was not associated with the risk for diabetes. In the Cox regression model, the GADAlow and GADAhigh exhibited 2.63-fold and 4.16-fold increased risk for diabetes, respectively. This increased risk for diabetes by GADA-positivity is only found in male adults (HR 4.55, 95% CI 2.25-9.23).
Conclusion: GADA has a low prevalence in China but is associated with a 2.63-4.16-fold increased risk for diabetes.
Keywords: autoimmune diabetes; glutamic acid decarboxylase antibody; latent autoimmune diabetes in adults; obesity; prevention.
© 2021 Li et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures
Similar articles
-
Persistence of glutamic acid decarboxylase antibody (GADA) is associated with clinical characteristics of latent autoimmune diabetes in adults: a prospective study with 3-year follow-up.Diabetes Metab Res Rev. 2016 Sep;32(6):615-22. doi: 10.1002/dmrr.2779. Epub 2016 Mar 3. Diabetes Metab Res Rev. 2016. PMID: 26787598
-
[Detection of antibodies against pancreatic islet cells in clinical practice].Orv Hetil. 1999 Nov 28;140(48):2695-701. Orv Hetil. 1999. PMID: 10645715 Clinical Trial. Hungarian.
-
The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3.Diabetes Care. 2008 Mar;31(3):534-8. doi: 10.2337/dc07-1457. Epub 2007 Dec 4. Diabetes Care. 2008. PMID: 18056891
-
[Latent autoimmune diabetes of adult or slim type 2 diabetes mellitus?].Arq Bras Endocrinol Metabol. 2008 Mar;52(2):315-21. doi: 10.1590/s0004-27302008000200019. Arq Bras Endocrinol Metabol. 2008. PMID: 18438542 Review. Portuguese.
-
International Workshop on Lessons From Animal Models for Human Type 1 Diabetes: identification of insulin but not glutamic acid decarboxylase or IA-2 as specific autoantigens of humoral autoimmunity in nonobese diabetic mice.Diabetes. 2001 Nov;50(11):2451-8. doi: 10.2337/diabetes.50.11.2451. Diabetes. 2001. PMID: 11679421 Review.
Cited by
-
Lifestyle or Environmental Influences and Their Interaction With Genetic Susceptibility on the Risk of LADA.Front Endocrinol (Lausanne). 2022 Jun 29;13:917850. doi: 10.3389/fendo.2022.917850. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35846274 Free PMC article. Review.
-
Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive.Clin Mol Hepatol. 2025 Apr;31(2):474-488. doi: 10.3350/cmh.2024.0416. Epub 2024 Dec 30. Clin Mol Hepatol. 2025. PMID: 39736267 Free PMC article.
References
-
- National Diabetes Co-operative Study Group (1981). A mass survey of diabetes mellitus in a population of 300,000 in 24 provinces and municipalities in China. Zhonghua Nei Ke Za Zhi. 1981;20(20):678–683. - PubMed
-
- International Diabetes Federation. IDF diabetes atlas [Internet]. 9th ed.; 2019. Available from: http://www.diabetesatlas.org. Accessed December18, 2020.
LinkOut - more resources
Full Text Sources
Other Literature Sources